Institutional Ownership Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX). We have compiled data on the 67 institutions that hold shares in the stock, with a total of 44.9 Million shares, which have been reported (via 13F filing form) to have a value of $108 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
116,475
shares
|
$279,540
0.0% of portfolio
|
Q1 2025
Reduced 63.69%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
105,294
shares
|
$252,705
0.0% of portfolio
|
Q1 2025
Reduced 87.03%
|
|
Forefront Analytics, LLC
West Conshohocken, PA |
May 13, 2025 Q1 2025 |
100,070
shares
|
$240,168
0.07% of portfolio
|
Q1 2025
Added 55.73%
|
|
Universal Beteiligungs Und Servicegesellschaft Mb H
Frankfurt Am Main, 2M |
May 06, 2025 Q1 2025 |
97,123
shares
|
$233,095
0.0% of portfolio
|
Q1 2025
New holding
|
|
Congress Park Capital LLC
|
Jul 11, 2025 Q2 2025 |
95,422
shares
|
$229,012
0.08% of portfolio
|
Q2 2025
Reduced 85.84%
|
|
Aspire Growth Partners LLC
Miromar Lakes, FL |
May 14, 2025 Q1 2025 |
92,254
shares
|
$221,409
0.08% of portfolio
|
Q1 2025
Added 126.22%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
85,539
shares
|
$205,293
0.0% of portfolio
|
Q1 2025
New holding
|
|
Prudential Financial Inc
Newark, NJ |
May 13, 2025 Q1 2025 |
81,500
shares
|
$195,600
0.0% of portfolio
|
Q1 2025
Added 26.75%
|
|
Velan Capital Investment Management LP
Alpharetta, GA |
May 15, 2025 Q1 2025 |
75,000
shares
|
$180,000
0.08% of portfolio
|
Q1 2025
Added 114.29%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
61,719
shares
|
$148,125
0.0% of portfolio
|
Q1 2025
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
60,584
shares
|
$145,401
0.0% of portfolio
|
Q1 2025
Added 358.93%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
54,808
shares
|
$131,539
0.0% of portfolio
|
Q1 2025
Reduced 0.54%
|
|
Commonwealth Equity Services, LLC
|
May 09, 2025 Q1 2025 |
54,243
shares
|
$130,183
0.0% of portfolio
|
Q1 2025
Added 1.88%
|
|
Miller Financial Services LLC
Marshall, MI |
May 05, 2025 Q1 2025 |
51,000
shares
|
$122,400
0.05% of portfolio
|
Q1 2025
Added 104.0%
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
47,036
shares
|
$112,886
0.01% of portfolio
|
Q1 2025
Reduced 67.57%
|
|
Russell Investments Group, Ltd.
|
May 13, 2025 Q1 2025 |
44,576
shares
|
$106,982
0.0% of portfolio
|
Q1 2025
Added 30.9%
|
|
Private Advisor Group, LLC
|
May 05, 2025 Q1 2025 |
44,002
shares
|
$105,604
0.0% of portfolio
|
Q4 2024
Reduced 15.67%
|
|
Lpl Financial LLC
Fort Mill, SC |
May 07, 2025 Q1 2025 |
42,315
shares
|
$101,556
0.0% of portfolio
|
Q4 2024
Added 10.44%
|
|
Simplex Trading, LLC
|
May 12, 2025 Q1 2025 |
33,853
shares
|
$81,247
0.0% of portfolio
|
Q1 2025
Added 6577.12%
|
|
Ajo Vista, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
33,121
shares
|
$79,490
0.17% of portfolio
|
Q3 2024
New holding
|
|
Traphagen Investment Advisors LLC
Oradell, NJ |
Apr 17, 2025 Q1 2025 |
30,500
shares
|
$73,200
0.0% of portfolio
|
Q4 2024
New holding
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
28,734
shares
|
$68,961
0.0% of portfolio
|
Q1 2025
Reduced 51.93%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
24,877
shares
|
$59,704
0.0% of portfolio
|
Q1 2025
Added 0.24%
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
19,962
shares
|
$47,908
0.0% of portfolio
|
Q1 2025
Reduced 7.81%
|
|
Vanguard Personalized Indexing Management, LLC
Oakland, CA |
May 13, 2025 Q1 2025 |
17,708
shares
|
$42,499
0.0% of portfolio
|
Q1 2025
Reduced 52.13%
|